Asthika Goonewardene
Stock Analyst at Truist Securities
(1.38)
# 3,548
Out of 5,008 analysts
92
Total ratings
38.64%
Success rate
-10.44%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Asthika Goonewardene
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| RCUS Arcus Biosciences | Reiterates: Buy | $32 → $39 | $14.65 | +166.21% | 2 | Oct 7, 2025 | |
| MRUS Merus | Downgrades: Hold | $88 → $97 | $94.41 | +2.74% | 3 | Sep 29, 2025 | |
| JANX Janux Therapeutics | Initiates: Buy | $100 | $23.76 | +320.96% | 1 | Sep 10, 2025 | |
| RVMD Revolution Medicines | Initiates: Buy | $99 | $49.12 | +101.55% | 1 | Sep 5, 2025 | |
| MRSN Mersana Therapeutics | Maintains: Buy | $250 → $36 | $8.35 | +331.14% | 5 | Aug 14, 2025 | |
| GILD Gilead Sciences | Upgrades: Buy | $108 → $127 | $116.85 | +8.69% | 2 | Aug 8, 2025 | |
| EXEL Exelixis | Maintains: Buy | $56 → $49 | $39.19 | +25.03% | 11 | Jul 29, 2025 | |
| GMAB Genmab | Maintains: Buy | $45 → $46 | $32.74 | +40.50% | 15 | Jul 8, 2025 | |
| BNTX BioNTech SE | Reiterates: Buy | $151 → $155 | $107.04 | +44.81% | 3 | Jun 3, 2025 | |
| LEGN Legend Biotech | Maintains: Buy | $88 → $71 | $32.43 | +118.93% | 2 | May 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $14 → $10 | $1.44 | +594.44% | 7 | May 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $11 → $10 | $1.70 | +488.24% | 4 | Apr 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $25 → $15 | $2.26 | +563.72% | 6 | Mar 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $35 | $23.17 | +51.06% | 1 | Jan 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $87 → $136 | $85.58 | +58.92% | 5 | Nov 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $18 → $15 | $0.86 | +1,649.68% | 6 | Aug 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $5 → $4 | $1.85 | +116.22% | 5 | May 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $19 | $2.69 | +606.32% | 3 | May 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $27 | $0.89 | +2,949.81% | 2 | Sep 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Hold | $120 | $20.60 | +482.52% | 1 | Apr 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $100 → $60 | $2.06 | +2,812.62% | 3 | Aug 23, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $228 → $180 | $6.22 | +2,793.89% | 4 | Aug 23, 2022 |
Arcus Biosciences
Oct 7, 2025
Reiterates: Buy
Price Target: $32 → $39
Current: $14.65
Upside: +166.21%
Merus
Sep 29, 2025
Downgrades: Hold
Price Target: $88 → $97
Current: $94.41
Upside: +2.74%
Janux Therapeutics
Sep 10, 2025
Initiates: Buy
Price Target: $100
Current: $23.76
Upside: +320.96%
Revolution Medicines
Sep 5, 2025
Initiates: Buy
Price Target: $99
Current: $49.12
Upside: +101.55%
Mersana Therapeutics
Aug 14, 2025
Maintains: Buy
Price Target: $250 → $36
Current: $8.35
Upside: +331.14%
Gilead Sciences
Aug 8, 2025
Upgrades: Buy
Price Target: $108 → $127
Current: $116.85
Upside: +8.69%
Exelixis
Jul 29, 2025
Maintains: Buy
Price Target: $56 → $49
Current: $39.19
Upside: +25.03%
Genmab
Jul 8, 2025
Maintains: Buy
Price Target: $45 → $46
Current: $32.74
Upside: +40.50%
BioNTech SE
Jun 3, 2025
Reiterates: Buy
Price Target: $151 → $155
Current: $107.04
Upside: +44.81%
Legend Biotech
May 14, 2025
Maintains: Buy
Price Target: $88 → $71
Current: $32.43
Upside: +118.93%
May 14, 2025
Maintains: Buy
Price Target: $14 → $10
Current: $1.44
Upside: +594.44%
Apr 1, 2025
Maintains: Buy
Price Target: $11 → $10
Current: $1.70
Upside: +488.24%
Mar 3, 2025
Maintains: Buy
Price Target: $25 → $15
Current: $2.26
Upside: +563.72%
Jan 8, 2025
Initiates: Buy
Price Target: $35
Current: $23.17
Upside: +51.06%
Nov 12, 2024
Maintains: Buy
Price Target: $87 → $136
Current: $85.58
Upside: +58.92%
Aug 16, 2024
Maintains: Buy
Price Target: $18 → $15
Current: $0.86
Upside: +1,649.68%
May 21, 2024
Maintains: Buy
Price Target: $5 → $4
Current: $1.85
Upside: +116.22%
May 16, 2024
Maintains: Buy
Price Target: $19
Current: $2.69
Upside: +606.32%
Sep 6, 2023
Reiterates: Buy
Price Target: $27
Current: $0.89
Upside: +2,949.81%
Apr 5, 2023
Reinstates: Hold
Price Target: $120
Current: $20.60
Upside: +482.52%
Aug 23, 2022
Maintains: Hold
Price Target: $100 → $60
Current: $2.06
Upside: +2,812.62%
Aug 23, 2022
Maintains: Buy
Price Target: $228 → $180
Current: $6.22
Upside: +2,793.89%